Distribution, CR rate, PFS, and OS of 157 patients with DLBCL according to immunophenotype (GCB vs non-GCB)
| Algorithm . | n (%) . | CR rate, n (%) . | 5-year PFS . | 5-year OS . |
|---|---|---|---|---|
| Colomo | ||||
| GCB | 53 (44%) | 39 (74%) | 48% | 54% |
| Non-GCB | 68 (56%) | 53 (78%) | 55% | 62% |
| Hans | ||||
| GCB | 61 (41%) | 47 (77%) | 54% | 60% |
| Non-GCB | 88 (59%) | 67 (76%) | 52% | 59% |
| Muris | ||||
| GCB | 87 (57%) | 63 (72%) | 48% | 57% |
| Non-GCB | 65 (43%) | 51 (78%) | 56% | 63% |
| Choi | ||||
| GCB | 45 (33%) | 32 (71%) | 48% | 54% |
| Non-GCB | 90 (67%) | 70 (78%) | 52% | 61% |
| Tally | ||||
| GCB | 55 (37%) | 45 (82%) | 63% | 56% |
| Non-GCB | 92 (63%) | 65 (71%) | 54% | 47% |
| Algorithm . | n (%) . | CR rate, n (%) . | 5-year PFS . | 5-year OS . |
|---|---|---|---|---|
| Colomo | ||||
| GCB | 53 (44%) | 39 (74%) | 48% | 54% |
| Non-GCB | 68 (56%) | 53 (78%) | 55% | 62% |
| Hans | ||||
| GCB | 61 (41%) | 47 (77%) | 54% | 60% |
| Non-GCB | 88 (59%) | 67 (76%) | 52% | 59% |
| Muris | ||||
| GCB | 87 (57%) | 63 (72%) | 48% | 57% |
| Non-GCB | 65 (43%) | 51 (78%) | 56% | 63% |
| Choi | ||||
| GCB | 45 (33%) | 32 (71%) | 48% | 54% |
| Non-GCB | 90 (67%) | 70 (78%) | 52% | 61% |
| Tally | ||||
| GCB | 55 (37%) | 45 (82%) | 63% | 56% |
| Non-GCB | 92 (63%) | 65 (71%) | 54% | 47% |